Significantly improved upper gastrointestinal (UGI)...

Gastroenterology 2001 Vol. 120; Iss. 5-supp-S1

Significantly improved upper gastrointestinal (UGI) telerability with celecoxib, a COX-2 specific inhibitor, compared with conventional NSAIDs. The SUCCESS I trial

Jay L. Goldstein, Naurang Agrawal, Glenn M. Eisen, William Stenson, Al E. Bello, John G. Fort, Susan P. Boots
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
120
Year:
2001
Language:
english
DOI:
10.1016/s0016-5085(08)80516-1
File:
PDF, 176 KB
english, 2001
Conversion to is in progress
Conversion to is failed